
Sign up to save your podcasts
Or
This week, the CDC reported that breakthrough infections are rare among the first 101 million fully vaccinated people; tai chi is found to be effective to reduce belly fat in older adults; the CDC’s COVID-19 vaccine safety group says its reviewed ‘few’ reports of myocarditis in young people; a follow-up analysis supports tocilizumab in moderate-to-severe COVID-19-associated pneumonia; and lidocaine throat spray reduces cough frequency in patients with refractory chronic cough.
Read the full coverage here:
Breakthrough infections rare among first 101 million fully vaccinated people, CDC finds
Tai chi ‘effective approach’ in reducing belly fat in older adults
CDC’s COVID-19 vaccine safety group reviews ‘few’ reports of myocarditis in young people
Trial supports tocilizumab in moderate-to-severe COVID-19-associated pneumonia
Lidocaine throat spray reduces cough frequency in patients with refractory chronic cough
5
1313 ratings
This week, the CDC reported that breakthrough infections are rare among the first 101 million fully vaccinated people; tai chi is found to be effective to reduce belly fat in older adults; the CDC’s COVID-19 vaccine safety group says its reviewed ‘few’ reports of myocarditis in young people; a follow-up analysis supports tocilizumab in moderate-to-severe COVID-19-associated pneumonia; and lidocaine throat spray reduces cough frequency in patients with refractory chronic cough.
Read the full coverage here:
Breakthrough infections rare among first 101 million fully vaccinated people, CDC finds
Tai chi ‘effective approach’ in reducing belly fat in older adults
CDC’s COVID-19 vaccine safety group reviews ‘few’ reports of myocarditis in young people
Trial supports tocilizumab in moderate-to-severe COVID-19-associated pneumonia
Lidocaine throat spray reduces cough frequency in patients with refractory chronic cough